Literature DB >> 23489958

Pamidronate enhances bacterial adhesion to bone hydroxyapatite. Another puzzle in the pathology of bisphosphonate-related osteonecrosis of the jaw?

Marcin Kos1, Adam Junka, Danuta Smutnicka, Marzenna Bartoszewicz, Tomasz Kurzynowski, Karolina Gluza.   

Abstract

PURPOSE: Bacterial colonization of the denuded bone in bisphosphonate-related osteonecrosis of the jaw suggests that bisphosphonates increase bacterial adhesion and biofilm formation. This study evaluated the adhesion of gram-positive and gram-negative bacteria on hydroxyapatite coated with pamidronate, one of the most potent bisphosphonates.
MATERIALS AND METHODS: Twenty-five Staphylococcus aureus and 25 Pseudomonas aeruginosa strains were cultured on pamidronate-coated and uncoated hydroxyapatite discs. After incubation, nonadherent bacteria were removed by rinsing and centrifugation. Formation of a biofilm was confirmed by confocal laser 3-dimensional and scanning electron microscopy. The number of bacterial colonies was counted using quantitative cultures and mean numbers were compared using the Mann-Whitney rank sum test (statistical significance defined as P ≤ .05). The Hartree-Fock method was used for the calculation of electron interactions between hydroxyapatite ions and pamidronate.
RESULTS: Fold increases in the number of colonies formed by S aureus and P aeruginosa in the presence of pamidronate compared with controls were 7.19 ± 4.127 and 2.87 ± 0.622, respectively. Hartree-Fock analysis showed that the reactive NH3(+) group of pamidronate may act as a steric factor, facilitating anchoring of bacteria to the hydroxyapatite surface. Alternatively, the NH3(+) group may attract bacteria by direct electrostatic interaction.
CONCLUSIONS: Increased bacterial adhesion in the presence of bisphosphonates can promote osteomyelitis in patients with bisphosphonate-related osteonecrosis of the jaw. There may be increased infection rates when bisphosphonates are used for stabilization of prostheses in joint arthroplasty and in osteotomies and open fractures in patients treated with bisphosphonates.
Copyright © 2013 American Association of Oral and Maxillofacial Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23489958     DOI: 10.1016/j.joms.2012.12.005

Source DB:  PubMed          Journal:  J Oral Maxillofac Surg        ISSN: 0278-2391            Impact factor:   1.895


  17 in total

1.  Microbial biofilms are able to destroy hydroxyapatite in the absence of host immunity in vitro.

Authors:  Adam Feliks Junka; Patrycja Szymczyk; Danuta Smutnicka; Marcin Kos; Iryna Smolina; Marzenna Bartoszewicz; Edward Chlebus; Michal Turniak; Parish P Sedghizadeh
Journal:  J Oral Maxillofac Surg       Date:  2014-12-24       Impact factor: 1.895

2.  Polymicrobial oral conventionalization model in mice.

Authors:  Maria Imaculada de Queiroz Rodrigues; Camila Carvalho de Oliveira Coelho; Fabrício Bitu Sousa; Lidiany Karla Azevedo Rodrigues Gerage; Mário Rogério Lima Mota; Ana Paula Negreiros Nunes Alves
Journal:  Braz J Microbiol       Date:  2022-03-04       Impact factor: 2.214

3.  IL-36 Induces Bisphosphonate-Related Osteonecrosis of the Jaw-Like Lesions in Mice by Inhibiting TGF-β-Mediated Collagen Expression.

Authors:  Sol Kim; Drake W Williams; Cindy Lee; Terresa Kim; Atsushi Arai; Songtao Shi; Xinmin Li; Ki-Hyuk Shin; Mo K Kang; No-Hee Park; Reuben H Kim
Journal:  J Bone Miner Res       Date:  2016-10-12       Impact factor: 6.741

4.  Morphological and immunohistochemical features of tooth extraction sites in rats treated with alendronate, raloxifene, or strontium ranelate.

Authors:  Valesca Sander Koth; Fernanda Gonçalves Salum; Maria Antonia Zancanaro de Figueiredo; Karen Cherubini
Journal:  Clin Oral Investig       Date:  2020-09-23       Impact factor: 3.573

Review 5.  Pathophysiology of Osteonecrosis of the Jaws.

Authors:  Tara Aghaloo; Renna Hazboun; Sotirios Tetradis
Journal:  Oral Maxillofac Surg Clin North Am       Date:  2015-09-26       Impact factor: 2.802

6.  Treatment of Medication-Related Osteonecrosis of the Jaw and its Impact on a Patient's Quality of Life: A Single-Center, 10-Year Experience from Southern Italy.

Authors:  Giacomo Oteri; Gianluca Trifirò; Matteo Peditto; Loredana Lo Presti; Ilaria Marcianò; Francesco Giorgianni; Janet Sultana; Antonia Marcianò
Journal:  Drug Saf       Date:  2018-01       Impact factor: 5.606

7.  Incidence and risk predictors for osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates.

Authors:  Marcin Kos
Journal:  Arch Med Sci       Date:  2015-04-23       Impact factor: 3.318

Review 8.  Basic research and clinical applications of bisphosphonates in bone disease: what have we learned over the last 40 years?

Authors:  Xiao-Long Xu; Wen-Long Gou; Ai-Yuan Wang; Yu Wang; Quan-Yi Guo; Qiang Lu; Shi-Bi Lu; Jiang Peng
Journal:  J Transl Med       Date:  2013-12-11       Impact factor: 5.531

Review 9.  Is bisphosphonate-related osteonecrosis of the jaw an infection? A histological and microbiological ten-year summary.

Authors:  A M Hinson; C W Smith; E R Siegel; B C Stack
Journal:  Int J Dent       Date:  2014-06-24

Review 10.  Infection as an Important Factor in Medication-Related Osteonecrosis of the Jaw (MRONJ).

Authors:  Sven Otto; Suad Aljohani; Riham Fliefel; Sara Ecke; Oliver Ristow; Egon Burian; Matthias Troeltzsch; Christoph Pautke; Michael Ehrenfeld
Journal:  Medicina (Kaunas)       Date:  2021-05-09       Impact factor: 2.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.